Two Genmab (GMAB) directors sell shares at DKK 3,540.87 per share.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Two Genmab A/S (GMAB) directors, Martin Schultz and Mijke Zachariasse, sold shares on November 12, 2026. Schultz sold 617 shares and Zachariasse sold 351 shares, with each transaction priced at DKK 3,540.87. These transactions were disclosed in accordance with Article 19 of Regulation No. 596/2014 on Market Abuse.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.